SMAD4

Yasamin Mirzabeigi1, Nikunj Shah1, Kayla R Schwartz2

  • 1Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.

概括

患有SMAD4缺陷 (dSMAD4) 高度形态的结直肠腺癌 (CRC) 的患者预后不佳. 这些瘤迅速转移,但CDX2或SATB2免疫标记有助于诊断.